artificial intelligence
artificial intelligence
Unlocking AI in Cell Therapy: Start Small for Success!
Cell therapy developers must embrace AI cautiously. 🧬 Start small for gradual growth, ensuring long-term success and better ROI! 📈🤖
Unlocking Bioprocessing: Culture Biosciences & Google Cloud Team Up!
🌟 Culture Biosciences partners with Google Cloud! 🤖 AI integration will optimize bioprocessing, enhancing real-time monitoring and biomanufacturing. 📈🔬
Revolutionizing Bioprocessing: Achieving Quality by Design
1. 🌱 From Quality by Testing to Quality by Design: How the bioprocessing industry is embracing innovation for better efficiency and consistency. 🚀 2. 🏭 The Ongoing Journey to Quality by Design: Integrating AI, IoT, and digital twin tech for improved bioprocessing outcomes. 🌐
Revolutionizing Bioprocessing: Virtual Bioreactors & AI
📌 Discover how upstream bioprocessing is revolutionizing biotherapeutics with nondestructive monitoring, in silico modeling, and improved fluid dynamics! 🧪🔬🚀
Revolutionizing Bioprocessing: Boost Production and Achieve Scalability
🔍 Upstream bioprocessing can be more intense and stable with holistic monitoring and control technologies. 🔬 Experts discuss platforms for industrializing cell therapy, machine-learning-assisted clone selection, microbioreactors for modeling large-scale processes, and streamlined process analytical technology. 📊 These options can boost production and achieve a state of readiness in biomanufacturing. 🚀 The goal is to have a reliable and scalable platform from the start. 🧪 Artificial intelligence can help predict clone performance in intensified processes. 🌱 Clones optimized for fed-batch processes may not be ideal for perfusion processes. ⚙️ True perfusion processes should start with clones optimized for perfusion conditions.
CEO of Généthon Reveals Future of Gene Therapy
🔍 Frédéric Revah, CEO of Généthon, reflects on the past, present, and future of the organization in an interview. 🧬 Généthon was created in 1990 with a focus on gene therapy research for rare genetic diseases. 💡 Revah discusses the challenges of financing development for rare diseases and the need for equity in distribution. 🏭 Généthon is working on improving bioprocessing and reducing the cost of production for gene therapies. 🤝 The organization collaborates with partners in various fields to advance their research. ⚙️ Exciting developments include producing AAV in plants and using artificial intelligence to optimize bioreactors. ❌ The industry faces challenges such as improving the full-to-empty ratio of virus capsids. ❗️ Revah comments on the Pfizer incident and assures that Généthon is closely monitoring safety in their own clinical trial.
Revolutionizing Protein Purification with AI
🤖 Researchers in Austria 🧬 are using artificial intelligence to describe the 3D structure of therapeutic proteins. 🔬 📊 The AI helps design processes for purifying advanced therapies during manufacturing ⚙️. 🌟 Improve process development and understand protein biology using AI in the future. 🌟
Pharma’s Tech Revolution: AI and Synbio Supercharge Biologics
📰 Pharma is using new technologies like AI and synthetic biology to maximize biologics manufacturing. 💊 Innovations are improving antibody stability and yield, accelerating production and drug development. 🌐
